This company researches, develops & markets pharmaceutical products. It offers its products therapeutic area cancer, heart disease, inflammatory bowel disease & other chronic inflammatory diseases & also provides health supplements. This stock is trading up 6.5% to $6.05 in recent trading.
Today’s Range: $5.50-$6.50
52-Week Range: $1.47-$13.75
Volume: 40,000
Three-Month Average Volume: 34,074
From a technical perspective, NVGN is spiking notably higher here right off some near-term support at $5.50 with above-average volume. This stock has been uptrending very strong for the last month, with shares soaring from a low of $1.47 to its recent high of $7.15. During that move, shares of NVGN have been consistently making higher lows and higher highs, which is bullish technical price action. That move has now pushed NVGN within range of triggering a major breakout trade. That trade will hit once NVGN manages to take out some near-term overhead resistance at $6.98 to $7.15 with high volume.
Traders should now look for long-biased trades in NVGN as long as it’s trending above $5.50, and then once it sustains a move or close above those breakout levels with volume that hits near or above 34,074 shares. If NVGN triggers that breakout, then the stock will set up to re-test or possibly take out its next significant overhead resistance levels at $8.25 to $9.35. Any high-volume move above $9.35 will then put $11 into focus for shares of NVGN.
http://www.stockpickr.com/7-under-10-stocks-rising-explosive-volume.html?puc=yahoo&cm_ven=YAHOO
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM